Clinical Trials Logo
  1. Home
  2. Vasomotor Rhinitis
  3. NCT00979615

Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis

Vasomotor Rhinitis Clinical Trial

Clinical Trial Summary

The purpose of this study is to examine safety and efficacy of Patanase and Astelin in treating the symptoms of non-allergic vasomotor rhinitis (VMR).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00979615
Study type Interventional
Source Alcon Research
Contact
Status Completed
Phase Phase 4
Start date September 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT01509209 - Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis Phase 3
Completed NCT00745849 - Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial N/A
Recruiting NCT05348148 - Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis N/A
Completed NCT00118703 - Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis Phase 3
Completed NCT00682162 - Impact of Acupuncture on Vasomotor Rhinitis Phase 3
Completed NCT00415493 - Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation N/A
Completed NCT00976209 - Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED) Phase 3